fashion -WSS

fashion

author：knowledge 2025-08-04 03:36:25 - browse：77396

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： How to make over

explore

WSS

FDA greenlights medical device to combat bladder issues

Oak Street deal isn't the answer to health care's woes

Obesity drug from Roche shows promise in early study

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Intellia plays down concerns on accidental germline transmission

Study: Spinal cord stimulation helps patients with paralysis walk again

explore

fashion

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

The high cost of giving birth even with insurance

Republicans love RFK Jr. What's that tell us about health in 2024?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Abbott's new stent may help patients with peripheral artery disease

ChatGPT in medicine: STAT answers readers' burning questions

Roche's accidental data boosts hopes for anti

After affirmative action ruling, medical educators look to 'holistic review'

The White House hikes tariffs on plastic syringes made in China

hotspot

Hospital at home shows how to bring innovation to health care

FDA advisory panel to debate high blood pressure devices

Kellogg’s is going to war over Mexico’s nutrition label rules

Ripples from Flovent's discontinuation is killing children with asthma

Meadows told special counsel he could not recall Trump ever declassifying Mar

Hottest summer in 2,000 years puts focus on extreme heat, health

hotspot

knowledge

explore

entertainment